Skip to main content

Peer Review reports

From: Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

Original Submission
23 Mar 2021 Submitted Original manuscript
23 May 2021 Reviewed Reviewer Report - Shen Li
25 May 2021 Reviewed Reviewer Report - Paolo Schena
2 Aug 2021 Author responded Author comments - Qi Chen
Resubmission - Version 2
2 Aug 2021 Submitted Manuscript version 2
6 Sep 2021 Author responded Author comments - Qi Chen
Resubmission - Version 3
6 Sep 2021 Submitted Manuscript version 3
28 Sep 2021 Reviewed Reviewer Report - Alexander Gough
13 Nov 2021 Author responded Author comments - Qi Chen
Resubmission - Version 4
13 Nov 2021 Submitted Manuscript version 4
29 Nov 2021 Reviewed Reviewer Report - Muslim Syed
9 Dec 2021 Reviewed Reviewer Report - Shen Li
7 Jan 2022 Author responded Author comments - Qi Chen
Resubmission - Version 5
7 Jan 2022 Submitted Manuscript version 5
Publishing
15 Feb 2022 Editorially accepted
25 May 2022 Article published 10.1186/s13063-022-06336-3

You can find further information about peer review here.

Back to article page